Literature DB >> 16886084

Avidin and streptavidin ligands based on the glycoluril bicyclic system.

Pedro Hidalgo-Fernández1, Eva Ayet, Ivan Canal, Joan-Antoni Farrera.   

Abstract

Glycoluril derivatives with a carboxylic acid side chain have been synthesized and shown to bind to both avidin and streptavidin. Introduction of a valerate side chain in glycoluril led to an increased binding to both proteins only when the valerate group was bound to a N atom and with the proper stereochemistry [(+)-enantiomer]. On the other hand, introduction of the valerate side chain either on the bridgehead carbon or on the N atom with the opposite stereochemistry [(-)-enantiomer] led to a decrease in binding constant compared with unsubstituted glycoluril. Direct spectrophotometric competitive titration of each protein with a racemic ligand allowed measurement of the enantioselectivity of the ligand-protein complexation, together with the binding constant of the two enantiomers. In the case of the N-substituted glycoluril, the extension of the side chain by one methylene group, from valerate to caproate, led to an increase in the binding constant to both proteins. Docking studies using AutoDock 3.05 have been performed in order to predict the binding modes of these ligands to streptavidin. The effect of the stereochemistry and the position of the side chain on the binding constant to streptavidin is discussed in view of the predicted binding modes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886084     DOI: 10.1039/b605081f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Directed evolution of streptavidin variants using in vitro compartmentalization.

Authors:  Matthew Levy; Andrew D Ellington
Journal:  Chem Biol       Date:  2008-09-22

2.  Synthesis and characterization of the new ligand, 1,2,4-triazino[5,6-b]indol-3-ylimino methyl naphthalene-2-ol and its Ni(II) and Cu(II) complexes: comparative studies of their in vitro DNA and HSA Binding.

Authors:  Reem L B Alanazi; Mehvash Zaki; Wafa A Bawazir
Journal:  Biometals       Date:  2022-09-08       Impact factor: 3.378

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.